ArticlebioRxiv : the preprint server for biology2024

Recharacterization of RSL3 reveals that the selenoproteome is a druggable target in colorectal cancer.

Stephen L DeAngelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.